Suppr超能文献

格林-巴利综合征患者脑脊液的比较蛋白质组学分析

Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain-Barré syndrome.

作者信息

Yang Yin-Rong, Liu Shi-Lian, Qin Zhao-Yu, Liu Fu-Jun, Qin Yan-Jiang, Bai Shu-Mei, Chen Zhe-Yu

机构信息

Institute of Biochemistry and Molecular Biology, School of Medicine, Shandong University, 44 Wenhuaxi Road, Jinan, Shandong, P.R. China.

出版信息

Cell Mol Neurobiol. 2008 Aug;28(5):737-44. doi: 10.1007/s10571-007-9257-7. Epub 2008 Mar 15.

Abstract

To better understand the pathophysiologic mechanisms underlying Guillain-Barré syndrome (GBS), Comparative proteomic analysis of cerebrospinal fluid (CSF) between patients with GBS (the experiment group) and control subjects suffering from other neurological disorders (the control group) was carried out using two-dimensional gel electrophoresis (2-DE) technique, in combination with matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) and database searching to determine abnormal CSF proteins in GBS patients. Image analysis of 2-DE gels silver stained revealed that 10 protein spots showed significant differential expression between the two groups of CSF samples. The expression of cystatin C, transthyretin, apolipoprotein E and heat shock protein 70 were decreased. However, haptoglobin, alpha-1-antitrypsin, apolipoprotein A-IV and neurofilaments were elevated. The subsequent ELISA measured the concentration of cystatin C and confirmed the result of the proteomic analysis. These identified proteins may be involved in the pathophysiological process of GBS and call for further studying the role of these proteins in the pathogenesis of the disease.

摘要

为了更好地理解吉兰 - 巴雷综合征(GBS)潜在的病理生理机制,采用二维凝胶电泳(2-DE)技术,并结合基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)和数据库搜索,对GBS患者(实验组)和患有其他神经系统疾病的对照受试者(对照组)的脑脊液(CSF)进行了比较蛋白质组学分析,以确定GBS患者脑脊液中的异常蛋白质。对银染的2-DE凝胶进行图像分析显示,两组脑脊液样本之间有10个蛋白点呈现出显著的差异表达。胱抑素C、转甲状腺素蛋白、载脂蛋白E和热休克蛋白70的表达降低。然而,触珠蛋白、α-1抗胰蛋白酶、载脂蛋白A-IV和神经丝升高。随后的酶联免疫吸附测定(ELISA)检测了胱抑素C的浓度,并证实了蛋白质组学分析的结果。这些鉴定出的蛋白质可能参与了GBS的病理生理过程,需要进一步研究这些蛋白质在该疾病发病机制中的作用。

相似文献

1
Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain-Barré syndrome.
Cell Mol Neurobiol. 2008 Aug;28(5):737-44. doi: 10.1007/s10571-007-9257-7. Epub 2008 Mar 15.
2
Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients.
Eur J Neurol. 2007 May;14(5):563-8. doi: 10.1111/j.1468-1331.2007.01761.x.
3
Alteration of cystatin C levels in cerebrospinal fluid of patients with Guillain-Barré Syndrome by a proteomical approach.
Mol Biol Rep. 2009 Apr;36(4):677-82. doi: 10.1007/s11033-008-9228-1. Epub 2008 Mar 29.
5
Proteome analysis of cerebrospinal fluid in Guillain-Barré syndrome (GBS).
J Neuroimmunol. 2007 Apr;185(1-2):190-4. doi: 10.1016/j.jneuroim.2007.01.022. Epub 2007 Mar 26.
6
Protein profiling of Guillain-Barrè syndrome cerebrospinal fluid by two-dimensional electrophoresis and mass spectrometry.
Neurosci Lett. 2010 Nov 12;485(1):49-54. doi: 10.1016/j.neulet.2010.08.060. Epub 2010 Aug 27.
7
Evaluation of Apo A IV and Haptoglobin as Potential CSF Markers in Patients with Guillain-Barre´ Syndrome: A Cross-Sectional Study.
Neurol India. 2024 May 1;72(3):567-571. doi: 10.4103/neuroindia.NI_1914_20. Epub 2024 Jun 30.
8
Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis.
J Cell Mol Med. 2009 Aug;13(8A):1586-603. doi: 10.1111/j.1582-4934.2009.00850.x. Epub 2009 Jul 7.
9
Proteomic analysis of the cerebrospinal fluid of patients with lumbar disk herniation.
Proteomics. 2006 Feb;6(3):1019-28. doi: 10.1002/pmic.200500247.
10
Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand?
J Neurol. 2009 Jan;256(1):3-12. doi: 10.1007/s00415-009-0097-x. Epub 2009 Feb 16.

引用本文的文献

1
Current Biomarker Strategies in Autoimmune Neuromuscular Diseases.
Cells. 2023 Oct 15;12(20):2456. doi: 10.3390/cells12202456.
4
The Neuroimmunology of Guillain-Barré Syndrome and the Potential Role of an Aging Immune System.
Front Aging Neurosci. 2021 Jan 13;12:613628. doi: 10.3389/fnagi.2020.613628. eCollection 2020.
5
Thyroid Hormone Distributor Proteins During Development in Vertebrates.
Front Endocrinol (Lausanne). 2019 Aug 8;10:506. doi: 10.3389/fendo.2019.00506. eCollection 2019.
7
Variations in the cerebrospinal fluid proteome following traumatic brain injury and subarachnoid hemorrhage.
Pathophysiology. 2017 Sep;24(3):169-183. doi: 10.1016/j.pathophys.2017.04.003. Epub 2017 May 13.
10
Biomarkers of Guillain-Barré Syndrome: Some Recent Progress, More Still to Be Explored.
Mediators Inflamm. 2015;2015:564098. doi: 10.1155/2015/564098. Epub 2015 Sep 16.

本文引用的文献

1
Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients.
Eur J Neurol. 2007 May;14(5):563-8. doi: 10.1111/j.1468-1331.2007.01761.x.
2
Proteome analysis of cerebrospinal fluid in Guillain-Barré syndrome (GBS).
J Neuroimmunol. 2007 Apr;185(1-2):190-4. doi: 10.1016/j.jneuroim.2007.01.022. Epub 2007 Mar 26.
3
Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis.
J Neurochem. 2005 Dec;95(5):1461-71. doi: 10.1111/j.1471-4159.2005.03478.x.
4
Guillain-Barré syndrome.
Lancet. 2005 Nov 5;366(9497):1653-66. doi: 10.1016/S0140-6736(05)67665-9.
6
Cystatin C as a cerebrospinal fluid biomarker for pain in humans.
Pain. 2003 Apr;102(3):251-256. doi: 10.1016/S0304-3959(02)00403-7.
7
Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients.
Neurosci Lett. 2002 Mar 8;320(3):156-60. doi: 10.1016/s0304-3940(02)00047-2.
8
Dynamics of brain-derived proteins in cerebrospinal fluid.
Clin Chim Acta. 2001 Aug 20;310(2):173-86. doi: 10.1016/s0009-8981(01)00573-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验